| MR编号 | SE/H/0792/001 |
|---|
| 药品名称 | SmofKabiven |
|---|
| 活性成分 | - alanine 7.1 g
- arginine 6.1 g
- calcium chloride 0.28 g
- fish oil, rich in omega 3-acids 4.2 g
- glucose 42.0 %
- glucose monohydrate 127.0 g
- glycine 5.6 g
- histidine 1.5 g
- isoleucine 2.5 g
- leucine 3.8 g
- lysine 3.4 g
- magnesium sulfate 0.38 g
- medium-chain triglycerides 8.5 g
- methionine 2.2 g
- olive oil monohydrate 9.5 g
- phenylalanine 2.6 g
- potassium chloride 2.3 g
- proline 5.7 g
- serine 3.3 g
- sodium glycerophosphate 2.1 g
- sodium acetate 1.7 g
- soybean oil monohydrate 114.0 g
- taurine 0.5 g
- threonine 2.2 g
- tryptophan 1.0 g
- tyrosine 0.2 g
- valine 3.1 g
- zinc sulfate 0.0 g
|
|---|
| 剂型 | Emulsion for infusion |
|---|
| 上市许可持有人 | Fresenius Kabi AB
751 74 Uppsala
Sweden |
|---|
| 参考成员国 - 产品名称 | Sweden (SE) |
|---|
| 互认成员国 - 产品名称 | - Germany (DE)
- Denmark (DK)
- Belgium (BE)
- Netherlands (NL)
- Luxembourg (LU)
- Iceland (IS)
- United Kingdom (Northern Ireland) (XI)
- Ireland (IE)
- Austria (AT)
SmofKabiven zentral Emulsion zur Infusion - France (FR)
- Spain (ES)
- Portugal (PT)
- Greece (GR)
- Norway (NO)
- Finland (FI)
- Poland (PL)
Smofkabiven - Latvia (LV)
- Lithuania (LT)
SmofKabiven Central infuzinė emulsija - Estonia (EE)
- Hungary (HU)
SMOFKABIVEN emulziós infúzió - Bulgaria (BG)
- Cyprus (CY)
- Czechia (CZ)
- Romania (RO)
SMOFKABIVEN CENTRAL, emulsie perfuzabila - Slovakia (SK)
- Slovenia (SI)
|
|---|
| 许可日期 | 2008/04/16 |
|---|
| 最近更新日期 | 2024/04/25 |
|---|
| 药物ATC编码 | | 申请类型 | - TypeLevel1：Known Active Substance
- TypeLevel2：Initial Application
- TypeLevel3：Bibliographic Art 10 a Dir 2001/83/EC
- TypeLevel4：Chemical Substance
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|